Vivimed Labs share news, announcements and annual reports
NSE: VIVIMEDLABBSE: 532660Pharmaceuticals & BiotechnologySmall Cap
Vivimed Labs Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2005
Last close ₹5.42down ₹0.11 (1.99%)BSE ₹5.99
Share price at the NSE close on 2 Nov 2026. Previous close ₹5.53.
2 Nov: open ₹5.42, high ₹5.63, low ₹5.42
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹45 Cr3,293rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 27,808
Vivimed Labs board meetings
142 filed, newest first. Page 3 of 3.
Feb 2013
5 Feb · Board meeting
Inter alia to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2012.
Jan 2013
8 Jan · Board meeting
Nov 2012
6 Nov · Board meeting
Inter alia, to consider the Unaudited Financial Results for the quarter ended September 30, 2012.
Aug 2012
6 Aug · Board meeting
Inter alia to consider, approve and take on record the unaudited financial results of the Company for the quarter ended June 30, 2012.
May 2012
17 May · Board meeting
Inter alia, to consider the Audited Financial Results for financial year ended March 31, 2012 and to consider recommendation of final dividend for financial year ended March 31, 2012.
Jan 2012
30 Jan · Board meeting
Inter alia to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2011.
Nov 2011
16 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 14, 2011 have accepted resignation of Mr. Krishna Yeachuri and Mr. D Hanumantha Rao as Directors of the Company, And have Appointed Mr. Chunduri Ramakrishna and Mr. Srinivas Chidambaram as Additional Director.7 Nov · Board meeting
Inter alia to consider, approve and take on record the unaudited financial results of the Company for the quarter and half year ended September 30, 2011.
Aug 2011
5 Aug · Board meeting
Inter alia, to consider, approve and take on record the unaudited financial results of the Company for the quarter ended June 30, 2011.
May 2011
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 27, 2011 has taken following decisions: (1) Approved the issuance and allotment, by way of a private placement, unsecured foreign currency convertible bonds (the "FCCBs") up to an amount in the aggregate not exceeding US$ 7.50 Million (approximately Rs. 34 crores) to the International Finance Corporation. The relevant date for calculating the floor price of FCCBs shall be May 27,2011. (2) Approved calling of Extra Ordinary General Meeting on June 20, 2011, to seek shareholder approval for preferential issue of equity shares.18 May · Board meeting
Inter alia to consider and approve Audited Financial results of the Company for the quarter and year ended March 31, 2011.10 May · Board meeting
Board of Directors of the Company at its meeting held on May 06, 2011 approved the following : (1) Passed the resolution under Section 372A of the Companies Act, 1956 to make loan and/or to give guarantee, or to provide security, in connection with the loan made by any other person to or other person by and/or to acquire, by way of subscription, purchase or otherwise the securities of any company up to an amount of Rs.500 crores; (2) Passed resolution approving calling for extra-ordinary general meeting on May 31, 2011.
Jan 2011
18 Jan · Board meeting
Inter alia to consider, approve and take on record the Unaudited Financial Results of the Company for quarter and nine months ended December 31, 2010.
Oct 2010
12 Oct · Board meeting
Inter alia to consider and approve the unaudited financial results for the quarter ended on September 30, 2010.11 Oct · Board meeting
Board of Directors of the Company at the Board Meeting held on October 09, 2010 have inter alia taken the following decisions: (1) To raise funds through Global Depository Receipts (GDRs) and/or American Depository Receipts (ADRs) convertible into Equity Share and/or Foreign Currency Convertible Bonds (FCCBs) or Warrants convertible into depository receipts with underlying Equity Shares/Equity Shares ("Securities") and/or Qualified Institutional Placement upto an amount of US$ 25 million inclusive of premium; (2) To increase authorized share capital of the Company to Rs.20 Crores; (3) To increase FII Investment limits upto 49% of paid up shares capital; (4) To call for an Extra-Ordinary General Meeting of members of the Company on November 06, 2010.6 Oct · Board meeting
To consider further capital issue.
Aug 2010
5 Aug · Board meeting
Inter alia to: (1) Consider and approve the unaudited financial results for the quarter ended June 30, 2010 along with the related segment wise financial results.(2) Fix the date, time and venue of Annual General Meeting and to approve the draft notice convening the Annual General Meeting.(3) Fix the date of closure of Register of Members and Share Transfer Books of the Company for the purpose of dividend and Annual General Meeting.
May 2010
20 May · Board meeting
Inter alia to consider and take on record the audited standalone and consolidated financial results for the financial year ended on March 31, 2010.
Apr 2010
26 Apr · Board meeting
Board of Directors at their meeting held on April 24, 2010 resolved to issue 14,90,000 warrants convertible into Equity Shares of Rs. 10/- each at a premium of Rs. 140/- each to promoters and others for which the Company has already received In-principle approval from the Exchanges.20 Apr · Board meeting
To consider receipt of Warrant Application Money and allot warrants to the allottees.
Feb 2010
8 Feb · Board meeting
Board of Vivimed Labs Limited at their meeting held on February 05, 2010 passed resolution to call for and convene Extra Ordinary General Meeting of the shareholders on March 05, 2010 to obtain consent / approval of the members for: Issue of upto 15,00,000 Warrants on preferential basis at a issue price of Rs. 150 per warrant determined in accordance with relevant SEBI Regulations, convertible into Equity Shares of Rs. 10 fully paid up for each warrant, at the option of warrant holders, within 18 months from the date of allotment of warrants.3 Feb · Board meeting
Members of the Company in their Extra Ordinary General Meeting held on November 21, 2009 approved issue of Warrants on Preferential Basis. However, due to technical reasons, Company could not proceed with allotment of warrants. Hence Board of the Company, shall meet on February 05, 2010 to consider and decide on date of EGM to be held to reconsider and consent to allot Warrants on preferential basis, to the same persons approved in the EGM held on November 21, 2009.
Jan 2010
21 Jan · Board meeting
Meeting on 29 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
20 Oct · Board meeting
Meeting on 27 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”12 Oct · Board meeting
To consider issue of Preferential Shares / Warrants and other business as per agenda.
Jul 2009
23 Jul · Board meeting
Meeting on 31 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
23 Jun · Board meeting
Inter-alia to consider and take on record and approve the Audited Financial Results for the year ended March 31, 2009 and other items as per the agenda.
Jan 2009
20 Jan · Board meeting
Inter-alia to consider and take on record and approve the un-audited financial results for the quarter ended December 31, 2008 and other items as per the agenda.
Oct 2008
20 Oct · Board meeting
Inter-alia to consider and take on record and approve the un-audited financial results for the quarter ended September 30, 2008 and other items as per the agenda.
Jul 2008
22 Jul · Board meeting
Inter-alia to consider and take on record and approve the un-audited financial results for the quarter ended June 30, 2008 and other items as per the agenda.
Jun 2008
20 Jun · Board meeting
To consider, inter alia, the following items: (1) Approval of Audited Financial Statements for the year ended March 31, 2008. (2) Propose cancellation of Preferential issue of shares/warrants to promoters, Promoter groups and others. (3) Any other business with approval of the chair.
Mar 2008
14 Mar · Board meeting
A Meeting of the Board of Directors of the Company has been held at 4.00 P.M. on Wednesday, the 13th March 2008 at the Corporate Office of the Company, whereat the Board has resolved unanimously among other things, to: 1) Investment in shares and/or loan to Vivimed Holdings Limited, a 100% subsidiary of our Company. 2) Provide Corporate Guarantee to the lender of Vivimed Holdings Limited. The above decisions are consequent to Vivimed Labs Limited acquiring James Robinson Limited, a UK based company through its 100% subsidiary company and obtaining financial assistance from banks for this acquisition6 Mar · Board meeting
To consider, inter alia, the following items of business: 1) To consider the proposal of investment in Vivimed Holdings Limited, a 100% Subsidiary of the Company. 2) To consider the proposal of providing Corporate Guarantee to the lender to Vivimed Holdings Limited.
Jan 2008
16 Jan · Board meeting
To consider, inter alia, the following terms. (1) To consider and take on record and approve the Un-Audited financial results for the quarter ending December 31, 2007. (2) Appointment of new Directors. (3) Appointment of Chairman in place of Sri.Santosh Varalwar.
Dec 2007
20 Dec · Board meeting
To consider, inter alia, the following items: 1) Allotment of Shares pursuant to the Merger of VVS Pharmaceuticals Private Limited with VIVIMED Labs Limited; 2) To take note of the Karnataka High Court Order on Amalgamation with VVS Pharmaceuticals Private Ltd. and consider and take on record the Consolidated Audited Financial Results for the year ending 31-03-2007; 3) Appointment of Directors on the Board; 4) Any other business with approval of the chair".
Nov 2007
26 Nov · Board meeting
Inter alia the following items : 1) Adoption of Accounts for the year ended March 31, 2007. 2) The Proposal of issue of Shares/ warrants by way of preferential basis. 3) The Proposal for the Enhancement of Borrowing limits to the Board. 4) Increase of Managerial remuneration. 5) The Fixation if Book Closure. 6) The allotment of Shares pursuant to the Merger. 7) Any other item with permission of the Chair.
Oct 2007
23 Oct · Board meeting
Inter alia to consider and take on record and approve the Un-audited Financial Results for the quarter ended on September 30, 2007 and other business as per the agenda.
Jul 2007
23 Jul · Board meeting
Inter alia to consider and take on record and approve the Un-audited Financial Results for the quarter ending on June 30, 2007 and other business as per the agenda.
Apr 2007
23 Apr · Board meeting
Meeting on 30 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Jan 2007
24 Jan · Board meeting
Meeting on 30 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”